BCRX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: BCRX Shares Outstanding History and BCRX YTD Return |
BCRX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: BCRX Shares Outstanding History and BCRX YTD Return |
BCRX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+10.43% CAGR Mouse over chart for data details
|
BCRX Stock Price Chart |
About BioCryst Pharmaceuticals Inc |
BioCryst Pharmaceuticals is a commercial-stage biotechnology company that discovers oral, small-molecule medicines. Co. focuses on oral treatments for rare diseases. Co.'s drug/drug candidates include: ORLADEYO (berotralstat), an oral serine protease inhibitor targeting kallikrein that is being developed for the prevention of Hereditary Angioedema attacks; BCX9930, an oral factor D inhibitor for the treatment of complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors for the treatment of fibrodysplasia ossificans progressive; and RAPIVAB® (peramivir injection), an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza. We show 57 historical shares outstanding datapoints in our BCRX shares outstanding history coverage, used to compute BCRX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing BCRX market cap history over the course of time is important for investors interested in comparing BCRX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of BCRX versus a peer is one thing; comparing BCRX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like BCRX can fluctuate over the course of history. With this page we aim to empower investors researching BCRX by allowing them to research the BCRX market cap history. |
BCRX Current Stock Quote |
Free BCRX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
BCRX Share Performance |
Market Cap Peers |
BioCryst Pharmaceuticals (BCRX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
BDSI Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.